Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.
Press releases published on August 21, 2025
Delayed Symptoms: How Hidden Injuries Can Impact Personal Injury Cases
OPELOUSAS, LA, UNITED STATES, August 21, 2025 /EINPresswire.com/ -- Not all injuries reveal themselves immediately after an accident. For many individuals involved in workplace or personal injury cases, symptoms may take days, weeks, or even months to …
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
Regional Health Properties Reports Second Quarter & Six Month 2025 Financial Results
ATLANTA, GA , Aug. 21, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA) (OTCQB:RHEPZ, a self-managed healthcare real estate investment company that …
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
Utah Governor Spencer Cox opens 190,000-square-foot building Nusano platform capable of producing more than 40 different radioisotopes for healthcare and industry New supplies of radioisotopes urgently needed for new and emerging cancer diagnostics and …
BioSyent Releases Financial Results for Q2 and H1 2025
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q2) and six months (H1) ended June 30, 2025. Key highlights include: (CAD) Q2 2025 % Change vs. …
BioSyent Declares Third Quarter 2025 Dividend
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars …
Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025
FOSTER CITY, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …
AVITA Medical Announces September Investor Conference Participation
VALENCIA, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that senior management will participate in three investor …
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will …
Pneumococcal Infections Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight
New York, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pneumococcal Infections Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight The pneumococcal infection market is poised for steady growth, driven …
Global Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032 | DelveInsight
New York, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Global Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032 | DelveInsight The thyroid gland disorder treatments market is witnessing substantial growth, fueled by the …
PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics
BOSTON, Mass., and TAMPA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top cancer hospitals and a leader in cancer research, today …
Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
PITTSBURGH, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced an update on development plans for KB707, the Company’s redosable immunotherapy designed to drive …
BriaCell Announces Proposed Effective Date of Share Consolidation
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …
Memorial Health Group Launches Rememore to Redefine Luxury Medical Tourism
Photo: Rememore Healthcare ISTANBUL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Memorial Health Group has officially launched Rememore, a premium brand designed to transform the landscape of international medical tourism. By combining world-class healthcare with …
King Faisal Specialist Hospital hat 2024 fast 300.000 virtuelle Konsultationen angeboten
RIAD, Saudi-Arabien, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSHRC) hat im Jahr 2024 293.381 virtuelle Konsultationen durchgeführt, was einem Anstieg von 58,2 % gegenüber dem Vorjahr entspricht. Dieser …
King Faisal Specialist Hospital realiza cerca de 300,000 consultas virtuales en 2024
RIAD, Arabia Saudita, Aug. 21, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) realizó 293,381 visitas clínicas virtuales en 2024, lo que representa un aumento del 58,2% en comparación con el año anterior. El …
Le King Faisal Specialist Hospital a réalisé près de 300 000 consultations virtuelles en 2024
RIYAD, Arabie saoudite, 21 août 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) a réalisé 293 381 consultations virtuelles en 2024, soit une augmentation de 58,2 % par rapport à l’année précédente. Cette croissance …